We received a referral for a 51-year-old female patient who underwent a modified radical mastectomy for left breast cancer (pT2N3M0, stage IIIC, HER-2 positive) on April 21, 2021, after being treated at another hospital three years earlier. This evidence concerns the gene ERBB2 and breast carcinoma.